A randomized controlled trial on acupuncture treatment of diarrheal-predominant irritable bowel syndrome

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged between 18 and 75 years (no gender limitation);
•2. Meets the diagnostic criteria of diarrheal-predominant irritable bowel syndrome (IBS-D);
•3. Type 6 or 7 of the Bristol Stool Form Scale appeared for at least 4 days and type 1 or 2 appeared for less than 4 days in last 2 weeks; The average score of daily abdominal pain was >= 3 in the last week;
•4. No treatment of acupuncture in the last 6 months;
•5. No use of antidepressant or IBS medication within 2 weeks before treatment, including traditional Chinese medicine (TCM) or proprietary Chinese medicine, antidiarrheal, antispasmodic, intestinal antibiotics, probiotics and so on.

•1.Patients with the following diseases: inflammatory bowel disease, microscopic colitis, celiac disease, Crohn's disease and other organic bowel diseases;
•2.Diabetes mellitus and abnormal thyroid function;
•3.Severe acute or chronic organic diseases, kidney or liver diseases;
•4.History of abdominal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post-surgery are allowed.);
•5.Pregnancy or lactation;
•6.History of alcohol and drug abuse;
•7.Participating in other clinical trials.

发起方

Beijing University of Chinese Medicine